Pfizer and Allergan plan largest merger in pharma history

Deal could see Pfizer relocate outside of US for tax purposes

Drug pricing has drawn scrutiny from US lawmakers. Pic: Bloomberg

Pfizer and Allergan are considering a merger, the Wall Street Journal has reported. The deal could be among the largest in the drug industry’s history and give Pfizer control of the Botox cosmetic drug.

Pfizer recently approached Allergan and the process is at an early stage, according to reports. The talks could face obstacles such as agreeing on price, layoffs and closing of facilities.

With a combined market value exceeding $330 billion, a ...